Estimated Control Closed Deal verified ConsumerConsumer HealthcareConsumer Healthcare / OTC PharmaceuticalsOTC Pharmaceuticals
Boehringer Ingelheim Consumer Healthcare business acquired by Sanofi
Sanofi acquired Boehringer Ingelheim Consumer Healthcare business, a Global / Germany consumer healthcare / otc pharmaceuticals brand on Jun 27, 2016. FundComb records estimated consideration of USD 7.3bn. The current comp implies EV / revenue of 4.4x. Public sources confirm the deal; valuation inputs may include estimates where transaction materials do not disclose the full economics.
Transaction summary
- Target
- Boehringer Ingelheim Consumer Healthcare business
- Acquirer
- Sanofi
- Seller
- Boehringer Ingelheim
- Announced
- 2016-06-27
- Geography
- Global / Germany
- Tags
- ConsumerConsumer HealthcareConsumer Healthcare / OTC PharmaceuticalsOTC Pharmaceuticals
- Type
- Acquisition
- Deal type
- Control
- Stake acquired
- -
- First added
- 2026-06-19
- Latest update
- 2026-06-19
Value and multiples
Price / value
$7.3B
Enterprise Value | USD
Basis: Estimated
EV / revenue
4.4x
unknown
Basis: FundComb estimate
EV / EBITDA
16.1x
Basis: FundComb estimate
Basis
- USD 7.3bn enterprise value is a FundComb estimate. Public sources reviewed confirm the transaction, but do not independently disclose every valuation input.
- EV / revenue is shown as 4.4x based on the available comp inputs.
- Revenue and multiple inputs are not fully disclosed in public transaction materials reviewed; treat the multiple as an estimate.
- EV / EBITDA is shown as 16.1x based on the available comp inputs.
Source summary
No public source summary has been published for this transaction yet.